Does DACLATASVIR Cause Diffuse large b-cell lymphoma recurrent? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Diffuse large b-cell lymphoma recurrent have been filed in association with DACLATASVIR. This represents 0.1% of all adverse event reports for DACLATASVIR.
5
Reports of Diffuse large b-cell lymphoma recurrent with DACLATASVIR
0.1%
of all DACLATASVIR reports
0
Deaths
4
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma recurrent From DACLATASVIR?
Of the 5 reports, 4 (80.0%) required hospitalization.
Is Diffuse large b-cell lymphoma recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DACLATASVIR. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does DACLATASVIR Cause?
Fatigue (510)
Hepatocellular carcinoma (419)
Headache (411)
Hepatitis c (400)
Drug ineffective (385)
Treatment failure (310)
Nausea (287)
Anaemia (251)
Ascites (205)
Off label use (199)
What Other Drugs Cause Diffuse large b-cell lymphoma recurrent?
RITUXIMAB (1,359)
CYCLOPHOSPHAMIDE (1,007)
VINCRISTINE (957)
DOXORUBICIN (953)
PREDNISONE (738)
CYTARABINE (406)
DEXAMETHASONE (402)
ETOPOSIDE (375)
CISPLATIN (306)
GEMCITABINE (280)
Which DACLATASVIR Alternatives Have Lower Diffuse large b-cell lymphoma recurrent Risk?
DACLATASVIR vs DACLIZUMAB
DACLATASVIR vs DACOMITINIB
DACLATASVIR vs DACTINOMYCIN
DACLATASVIR vs DALBAVANCIN
DACLATASVIR vs DALFAMPRIDINE